Targeting Epstein-Barr virus-associated lymphomas.
Dana-Farber Cancer Institute, Boston, MA.
Sarah
S
Nikiforow
Ann S
AS
Lacasce
D005260:Female; D015316:Genetic Therapy / Q000379:methods*; D004854:Herpesvirus 4, Human / Q000276:immunology*; D006801:Humans; D016219:Immunotherapy, Adoptive / Q000379:methods*; D008223:Lymphoma / Q000628:therapy*; D008297:Male; D013602:T-Lymphocytes, Cytotoxic / Q000637:transplantation*; D014763:Viral Matrix Proteins / Q000276:immunology*
C037662:EBV-associated membrane antigen, Epstein-Barr virus; D014763:Viral Matrix Proteins